Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals

Inclusion Criteria: * HIV infection confirmed according to the criteria of the Department of Chronic Diseases and Sexually Transmitted Infections of the Brazilian Health Ministry; * Absence of the use of antineoplastic or corticosteroid therapies for a minimum period of six months prior to study entry; * Absence of comorbidities considered uncontrolled by researchers; * Viral load ≤ 40 copies/mL, stable (i.e., no \> 0.5 log) in the six months prior to the start of the study; * Blood count of CD4 T lymphocytes ≥ 500 cells/μL, stable (i.e., \>25%) in the six months prior to the start of the study; * Informed consent Exclusion Criteria: * Individuals without adequate venous access to the blood collection and apheresis procedure; * Use of drugs or alcohol in a way that interferes with patients' ability to follow the study requirements; * Pregnancy, breastfeeding or interest in becoming pregnant during the study period; * Presence of any other condition that, in the evaluation of researchers is able to promote alteration of the immune system, as well as any disorders that could affect understanding in the process of informed consent.